KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogenomics (NEO) Total Debt: 2009-2020

Historic Total Debt for Neogenomics (NEO) over the last 9 years, with Mar 2020 value amounting to $95.6 million.

  • Neogenomics' Total Debt rose 1.85% to $95.6 million in Q1 2020 from the same period last year, while for Mar 2020 it was $95.6 million, marking a year-over-year increase of 1.85%. This contributed to the annual value of $96.8 million for FY2019, which is 1.12% up from last year.
  • Latest data reveals that Neogenomics reported Total Debt of $95.6 million as of Q1 2020, which was down 1.26% from $96.8 million recorded in Q4 2019.
  • In the past 5 years, Neogenomics' Total Debt ranged from a high of $99.3 million in Q3 2019 and a low of $52.8 million during Q3 2016.
  • For the 3-year period, Neogenomics' Total Debt averaged around $93.9 million, with its median value being $96.8 million (2019).
  • As far as peak fluctuations go, Neogenomics' Total Debt surged by 47.79% in 2017, and later fell by 11.22% in 2018.
  • Over the past 5 years, Neogenomics' Total Debt (Quarterly) stood at $73.9 million in 2016, then fell by 4.78% to $70.4 million in 2017, then surged by 36.08% to $95.8 million in 2018, then rose by 1.12% to $96.8 million in 2019, then rose by 1.85% to $95.6 million in 2020.
  • Its last three reported values are $95.6 million in Q1 2020, $96.8 million for Q4 2019, and $99.3 million during Q3 2019.